Cadence Capital Management’s Hologic HOLX Stock Holding History

Cadence Capital Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-37,969	Closed	-$1.47M	–	648
2015 Q4	$1.47M	Sell	37,969 -511	-1%	-$19.9K	0.1%	226
2015 Q3	$1.51M	Buy	+38,480	New	+$1.53M	0.11%	218

Other funds holding HOLX

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCM

Tran Capital Management San Rafael, California $869M AUM 52.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cadence Capital Management's HOLX Position: Q1 2016 in Review

Cadence Capital Management sold out of Hologic (HOLX) in Q1 2016, closing a stake of 37,969 shares — an estimated $1.47M sold.

Cadence Capital Management first reported a position in HOLX in Q3 2015 and held it in 2 quarters. The position peaked at $1.51M in Q3 2015. 456 funds tracked by Wall St. Rank hold HOLX as of Q1 2016.

Cadence Capital Management reported no remaining Hologic position as of Q1 2016 after selling out during the quarter.
Cadence Capital Management sold 37,969 Hologic shares in Q1 2016, an estimated $1.47M.
Cadence Capital Management first reported a position in Hologic in Q3 2015 and held it in 2 quarters.
Cadence Capital Management's Hologic position peaked at $1.51M in Q3 2015.
456 funds tracked by Wall St. Rank held Hologic as of Q1 2016.

Based on Cadence Capital Management's 13F filing for Q1 2016, filed 2 May 2016.